Navigation Links
Optimer Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
Date:7/5/2012

SAN DIEGO, July 5, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced that the Company will present at the 7th Annual JMP Securities Healthcare Conference on Thursday, July 12 at 10:30 a.m. Eastern Time in New York, NY, and provide a business overview and update.

(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

A live audio webcast of the presentation will be accessible on the Investors page of the Company's website at www.optimerpharma.com.  Replays of the presentation will be available at the same location for 90 days following the presentation.

About Optimer Pharmaceuticals Optimer Pharmaceuticals, Inc. is a global biopharmaceutical company focused on developing and commercializing innovative hospital specialty products that have a positive impact on society. Optimer developed DIFICID® (fidaxomicin) tablets, an FDA-approved antibacterial drug for the treatment of adult patients with Clostridium difficile-associated diarrhea (CDAD) and is commercializing DIFICID in the US and Canada. Optimer also received marketing authorization for fidaxomicin tablets in the European Union where its partner, Astellas Pharma Europe, is commercializing fidaxomicin under the trade name DIFICLIR™. The company is exploring marketing authorization in other parts of the world where C. difficile has emerged as a serious health problem, including Asia. Additional information can be found at http://www.optimerpharma.com.

Contacts Optimer Pharmaceuticals, Inc. David Walsey, VP of Investor Relations and Corporate Communications (858) 964-3418

Canale Communications Jason I. Spark, Senior Vice President 619-849-6005
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Optimer Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
2. First sales of DIFICLIR™ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
3. Optimer Pharmaceuticals and Specialised Therapeutics Australia Collaborate to Commercialize Fidaxomicin for Clostridium difficile Infection in Australia and New Zealand
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
8. Icahn Issues Statement Regarding Amylin Pharmaceuticals
9. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
10. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
11. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... San MediTech, the industry leader in China ... announced its plan to attend the American Diabetes Association ... on June 5 th to 8 th ... (DGMS). The company plans to show industry experts and ... advancements made by Chinese medical device companies. San MediTech ...
(Date:6/2/2015)... -- CytRx Corporation (NASDAQ: CYTR ), a biopharmaceutical research ... it has reached an agreement to settle the stockholder ... Court of Chancery, which names as defendants a ... officers, and names the Company as a nominal defendant. ... Corp. Stockholder Derivative Litigation , C.A. No. 9864-VCL, relates ...
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/jrlgdj/electrophysiology ) ... Market by Product {Diagnostic Catheter (Conventional, Advanced, Ultrasound)), ... Recording, Generator, ICE, X-ray)) & Indication (AF, VT, ... to their offering. The global electrophysiology ... significant CAGR of 10.3% from 2014 to 2019 ...
Breaking Medicine Technology:San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 2San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 3San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 4CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 2Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 3
... 16, 2011 Misonix, Inc. (Nasdaq: ... manufactures, and markets innovative, therapeutic, ultrasonic products worldwide ... laparoscopic surgery, and other surgical and medical applications, ... with the exception of certain selected accounts, of ...
... 2011 Netsmart Technologies, Inc., a leading provider ... services organizations, has been presented with the National ... Year Award. Each March during ... recognizes a premier member that has demonstrated a ...
Cached Medicine Technology:Misonix Announces Change in Distribution of BoneScalpel™ Bone Cutting System in the U.S. 2Misonix Announces Change in Distribution of BoneScalpel™ Bone Cutting System in the U.S. 3Netsmart Technologies Named NACo Premier Partner of the Year 2Netsmart Technologies Named NACo Premier Partner of the Year 3
(Date:6/2/2015)... Colleen’s Dream Foundation , with fundraising help ... UNMC to support ovarian cancer research conducted by Cheng Wang, ... the Colleen’s Dream Foundation Board of Directors. , Cundiff says ... for Colleen’s Dream Foundation and they couldn’t have picked a ... is a rising star in the ovarian cancer world,” says ...
(Date:6/2/2015)... 02, 2015 Date: Thursday, June 4, ... Council Chamber, 494 N. Broad Street, 4th floor, Philadelphia, ... Hepatitis B Foundation will visit Philadelphia City Council ... hepatitis B and hepatitis C in Philadelphia’s at-risk populations. ... they have created, Hep B United Philadelphia (HBUP), will ...
(Date:6/2/2015)... 2015 While the movie box office ... books, comic books themselves are stepping into a new ... plans to produce educational comics in multiple languages that ... Sustainable Development - an international effort to address humanity’s ... education, sustainable energy, inequality, climate change and more. , ...
(Date:6/2/2015)... Join us for a new event in Westwood, New Jersey—the ... , who overcame her brain aneurysm during the summer of ... awareness and funds for brain aneurysm research. , Rhonda ... will be one less case of someone suffering from a ... the 1st Anniversary Awareness Walk in Honor of Rhonda ...
(Date:6/2/2015)... Barbara, CA (PRWEB) June 02, 2015 ... a scholarship fund set up by current and former ... Odajnyk, a beloved faculty member from 2002 until his ... integrity, keen intelligence, and depth of feeling, as well ... and fairytales. His capacities as an analyst, teacher, and ...
Breaking Medicine News(10 mins):Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 3Health News:Hepatitis B Foundation to Urge Philadelphia Leaders to Make Viral Hepatitis Prevention a Local Priority 2Health News:Can Comics Help the United Nations Save the World? 2Health News:Can Comics Help the United Nations Save the World? 3Health News:New Awareness Raising Event in Westwood, NJ to Benefit Renowned Brain Aneurysm Foundation 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 3
... development of ulcerative colitis , SATURDAY, May 1 (HealthDay News) ... against ulcerative colitis, a new study finds. , Ulcerative colitis ... lining of the rectum and colon, resulting in abdominal pain, ... diet was rich in oleic acid were far less likely ...
... Staar Visian ... , ... Visian ICL manufactured by STAAR is a good solution for individuals who have moderate to ... had little alternative but to correct their vision with contact lenses or glasses. For ...
... the journal of the American Academy of Ophthalmology, includes a ... degeneration (AMD) among Asians, and describes an innovative "bypass" laser ... occlusion (CRVO) avoid serious vision loss. Are Asians ... by Tien Yi Wong, MD, MPH, PhD, and Singapore Eye ...
... fatty acid that promotes brain development, researchers find , ... have higher levels of DHA -- an omega-3 fatty ... the brain -- when their breast-feeding mothers take DHA ... deficiency in DHA (docosahexaenoic acid) is common in very ...
... SATURDAY, May 1 (HealthDay News) -- Giving probiotics -- live, ... extremely low helps them gain weight, says a new study. ... 2 pounds 2 ounces or less. About half of them ... and Bifidobacterium infantis -- in tube feedings once ...
... study finds , SATURDAY, May 1 (HealthDay News) -- ... their Facebook profiles may very well be planning to ... than college age report having had sexual intercourse, according ... of intercourse being 16.9 years for males and 17.4 ...
Cached Medicine News:Health News:Olive Oil May Protect Against Bowel Disease 2Health News:Staar Visian ICL Solution to Near Sightedness 2Health News:Staar Visian ICL Solution to Near Sightedness 3Health News:Staar Visian ICL Solution to Near Sightedness 4Health News:AMD risk on the rise for Asians; retinal vein 'bypass' may help many CRVO patients 2Health News:AMD risk on the rise for Asians; retinal vein 'bypass' may help many CRVO patients 3Health News:DHA Supplements for Mom Good for Preemies 2Health News:Probiotics Beneficial for Tiniest Preemies 2Health News:Teens' Facebook Sex Talk May Not Be Just Talk 2
Adjustable tilt angle 0 to 20 Adjustable speed of 3-25 RPM Load capacity: 2.7 kg (6 lbs.) Ambient temperature range 4C to 65C Low voltage power is supplied by wall mount transformer...
... a high-quality four-place microplate shaker with variable ... is adjustable from 100 to 1350 cycles/minute. ... small orbit ensure effective shaking for microplate ... and easy to set for 0 to ...
Inquire...
Benchtop UV Incubator is designed to provide precise temperature control and uniformity throughout the chamber. Decontaminate chamber between experiments with built-in shortwave UV....
Medicine Products: